The cost-saving switch from inhaled corticosteroid-containing treatments to dual bronchodilation: a two-country projection of epidemiological and economic burden in chronic obstructive pulmonary disease

The cost-saving switch from inhaled corticosteroid-containing treatments to dual bronchodilation: a two-country projection of epidemiological and economic burden in chronic obstructive pulmonary disease

Purpose: The Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2018 recommendations support maintenance treatment with long-acting bronchodilators in most symptomatic patients with chronic obstructive pulmonary disease (COPD). While restricting the overuse of inhaled corticosteroids (ICS...

Full description

Bibliographic Details
Main Authors:	Kyriakos Souliotis, Luís Silva Miguel, Georgios Hillas, Margarida Borges, Giannis Papageorgiou, Diogo Viana, Joao Malhadeiro, Stéphane Soulard
Format:	Article
Language:	English
Published:	SAGE Publishing 2020-06-01
Series:	Therapeutic Advances in Respiratory Disease
Online Access:	https://doi.org/10.1177/1753466620926802

Similar Items

The Role of Dual Bronchodilation and the Conscientious Use of Inhaled Corticosteroid in COPD
by: Ricardo G. Figueiredo, et al.
Published: (2022-08-01)

Effect of allergic phenotype on treatment response to inhaled bronchodilators with or without inhaled corticosteroids in patients with COPD
by: Cheng S, et al.
Published: (2017-07-01)

Effective treatment of inhaled corticosteroid and bronchodilator for “lymphocytic interstitial pneumonia” in primary Sjögren's syndrome
by: Yuki Moriuchi, et al.
Published: (2024-01-01)

Inhaled Bronchodilators and Corticosteroids in the Management of Bronchiolitis Obliterans due to Allogenic Hematopoietic Stem Cell Transplantation
by: Vasiliki Epameinondas Georgakopoulou, et al.
Published: (2022-05-01)

Systematic Review of Inhaled Bronchodilator and Corticosteroid Therapies in Infants with Bronchopulmonary Dysplasia: Implications and Future Directions.
by: Brian J Clouse, et al.
Published: (2016-01-01)

Long-acting bronchodilators with or without inhaled corticosteroids and 30-day readmission in patients hospitalized for COPD
by: Bishwakarma R, et al.
Published: (2017-01-01)

Gaps In using bronchodilators, inhaled corticosteroids and influenza vaccine among 23 high- and low-income sites
by: Gnatiuc, L, et al.
Published: (2015)

Combination long acting β agonists-inhaled corticosteroids versus dual bronchodilation: a real conflict?
by: Marco Candela
Published: (2014-10-01)

Pembrolizumab-associated bronchiolitis in an elderly lung cancer patient required the treatment with an inhaled corticosteroid, erythromycin and bronchodilators
by: Takafumi Yamaya, et al.
Published: (2019-01-01)

Cardiovascular morbidity and the use of inhaled bronchodilators
by: Christine Macie, et al.
Published: (2008-03-01)

Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations
by: Calverley PM, et al.
Published: (2016-02-01)

Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids
by: Asche CV, et al.
Published: (2012-03-01)

Bronchodilators, Antibiotics, and Oral Corticosteroids Use in Primary Care for Children With Cough
by: Sankaran Krishnan MD, MPH, et al.
Published: (2019-02-01)

Reducing carbon footprint by switching to reusable soft-mist inhalers
by: Christer Janson, et al.
Published: (2023-05-01)

Inhaled corticosteroids in COPD.
by: Brightling, C, et al.
Published: (1999)

Variants in the interleukin 8 gene and the response to inhaled bronchodilators in cystic fibrosis
by: Larissa Lazzarini Furlan, et al.
Published: (2017-11-01)

Variants in the interleukin 8 gene and the response to inhaled bronchodilators in cystic fibrosis
by: Larissa Lazzarini Furlan, et al.
Published: (2017-11-01)

Uncovering the beneficial effects of inhaled bronchodilator in COPD: beyond forced spirometry
by: José Alberto Neder, et al.

Dual Bronchodilator in the Era of Triple Therapy
by: Papaioannou AI, et al.
Published: (2020-10-01)

Inhaled corticosteroids for asthma: impact of practice level device switching on asthma control
by: Lloyd Andrew, et al.
Published: (2009-01-01)

Inhaled corticosteroids and risk of fractures
by: Van Staa, T, et al.
Published: (2000)

COPD: an inhaled corticosteroid-resistant, oral corticosteroid-responsive condition.
by: Saha, S, et al.
Published: (2006)

Nebulization metered-dose inhaler and spacer in bronchodilator responsiveness testing: a retrospective study
by: Rongli Lu, et al.
Published: (2023-12-01)

"Show me the money": a fair criticism of economic studies on inhaled bronchodilators for COPD
by: Kostikas Konstantinos, et al.
Published: (2010-09-01)

Reply to: inhaled corticosteroids and adult asthma
by: Beasley, R, et al.
Published: (2019)

Use of inhaled corticosteroids and risk of fractures.
by: van Staa, T, et al.
Published: (2001)

Inhaled Corticosteroids and Bronchiectasis: Friend or Foe?
by: Miguel Angel Martinez-Garcia
Published: (2023-05-01)

Inhaled Corticosteroids and the Lung Microbiome in COPD
by: Holly R. Keir, et al.
Published: (2021-09-01)

Inhaled corticosteroids in the treatment of croup in children
by: S. I. Shatalina, et al.
Published: (2014-12-01)

Inhaled corticosteroids for the treatment of COVID-19
by: Mona Bafadhel, et al.
Published: (2022-11-01)

The effects of inhaled corticosteroids on healthy airways
by: Marchi, E, et al.
Published: (2024)

Inhaled corticosteroids and the increased risk of pneumonia
by: Lucía Marzoratti, et al.
Published: (2013-08-01)

The future of bronchodilation: looking for new classes of bronchodilators
by: Mario Cazzola, et al.
Published: (2019-12-01)

Estimating Inhaled Corticosteroid Exposure from Short-Acting β2-Agonist–Inhaled Corticosteroid Rescue
by: Lugogo N, et al.
Published: (2023-05-01)

Compare the Effect of Inhaled Corticosteroids and Systemic Corticosteroids on Sputum Microbiome of AECOPD
by: Nan Ma, et al.
Published: (2021-02-01)

Responses of FEV<sub>6</sub>, FVC, and FET to inhaled bronchodilator in the adult general population
by: Lundbäck Bo, et al.
Published: (2009-07-01)

Biophysical model to predict lung delivery from a dual bronchodilator dry-powder inhaler
by: Myrna B. Dolovich, et al.
Published: (2019-12-01)

Asthma and Therapeutics: Inhaled Corticosteroids, Corticosteroid Osteoporosis, and the Risk of Fracture in Chronic Asthma
by: Toogood John H
Published: (2005-03-01)

Inhaled corticosteroids in COPD (multiple letters) [1]
by: Hart, S, et al.
Published: (1999)

Inhaled corticosteroids and hip fracture: disease or drugs?
by: van Staa, T, et al.
Published: (2003)